Tokyo, Japan

Satoshi Sasamura

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Chuo-ku, JP (2015)
  • Tokyo, JP (2010 - 2018)

Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Renal Disease Treatment: The Contributions of Satoshi Sasamura

Introduction

Satoshi Sasamura, an accomplished inventor based in Tokyo, Japan, is renowned for his significant contributions to the field of medicinal chemistry. With a portfolio of three patents, Sasamura has made remarkable strides in developing compounds aimed at tackling kidney diseases. His work epitomizes the intersection of research and practical application in medical therapies.

Latest Patents

Among Satoshi Sasamura's latest innovations are two notable patents that focus on guanidinobenzoic acid esters. The first patent, which details a guanidinobenzoic acid ester compound, aims to provide a solution for preventing and treating kidney diseases. This compound exhibits trypsin inhibitory activity, making it a potential agent to substitute low-protein diet therapy and to treat related conditions such as chronic kidney disease and acute kidney injury.

In the second patent, the guanidinobenzoic acid compound further emphasizes its utility in preventing and treating renal diseases. By leveraging the discovered trypsin inhibitory action, this compound can also assist in the management of pancreatitis, gastroesophageal reflux disease, and other health concerns linked to trypsin activity.

Career Highlights

Satoshi Sasamura has had an illustrious career, working with leading pharmaceutical companies such as Astellas Pharma GmbH and Takeda Pharmaceutical Company Limited. His time in these esteemed organizations has allowed him to refine his expertise in drug development and therapeutic innovations.

Collaborations

Throughout his career, Sasamura has collaborated with notable individuals in the field, including Jiro Fujiyasu and Susumu Yamaki. These collaborations have been pivotal in enhancing research outcomes and fostering innovative thought in medicinal chemistry.

Conclusion

With a commitment to addressing critical health challenges, Satoshi Sasamura continues to push the boundaries of research in kidney disease treatment through innovative compounds. His contributions have not only garnered him patents but also positioned him as a significant figure in pharmaceutical innovation. Efforts like his are crucial for advancing medical science and improving patient care in nephrology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…